Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund is a registered fund series of Touchstone Strategic Trust (series S000035678). Net assets $15.4M as of 2023-09-30.
Showing 15 of 80 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| AbbVie Inc. | — | $470K | 305.96% |
| The Kroger Co. | — | $448K | 291.47% |
| Merck & Co., Inc | — | $443K | 288.68% |
| Kellogg Company | — | $443K | 288.44% |
| Verizon Communications Inc. | — | $441K | 287.40% |
| Johnson & Johnson | — | $431K | 280.85% |
| Eli Lilly & Co. | — | $430K | 279.83% |
| General Mills, Inc. | — | $429K | 279.61% |
| Pfizer Inc. | — | $413K | 268.71% |
| Humana Inc. | — | $410K | 266.77% |
| The Clorox Company | — | $402K | 261.93% |
| Yum China Holdings Inc. | — | $396K | 257.70% |
| United Therapeutics Corporation | — | $388K | 252.70% |
| Newmont Corporation | — | $388K | 252.68% |
| Hormel Foods Corp | — | $381K | 248.37% |
| Report date | Net assets |
|---|---|
| 2023-09-30 | $15.4M |
| 2023-06-30 | $16.5M |
| 2023-03-31 | $22.0M |
| 2022-12-31 | $22.8M |
| 2022-09-30 | $21.8M |
| 2022-06-30 | $23.6M |
| 2022-03-31 | $26.6M |
| 2021-12-31 | $29.1M |